Robert Brodsky/X
Apr 29, 2026, 17:25
Robert Brodsky: Ravulizumab Appears To Be Safe And Effective In Pregnancy
Robert Brodsky, Chief of Hematology at Johns Hopkins, has shared a post on X about a recent article he and his colleagues co-authored, published in Blood Advances:
”Ravulizumab appears to be safe and effective in pregnancy. We’ve been waiting for this data for a long time.”
Title: Ravulizumab for Treatment of Paroxysmal Nocturnal Hemoglobinuria During Pregnancy
Authors: Britta Höchsmann, Gloria F Gerber, Wilhelm Leopold, Bhumika J Patel, Eleni Gavriilaki, Almut Hefter, Ursula Kalhammer, Sabine Anna Opitz, Astrid Marx-Hoffmann, Daniel B. Knight, Robert A. Brodsky, Anastasia Marvaki, Chrysavgi Lalayanni, Sixten Körper, Daria V. Babushok, Hubert Schrezenmeier

Stay updated on all scientific advances with Hemostasis Today.
Almut Hefter
Anastasia Marvaki
Astrid Marx-Hoffmann
Bhumika J Patel
Britta Höchsmann
Chrysavgi Lalayanni
Daniel B. Knight
Daria V. Babushok
Eleni Gavriilaki
Gloria F. Gerber
Health
Hematology
Hemostasis News
Hemostasis Today
Hubert Schrezenmeier
Medicine
Pregnancy
Ravulizumab
Robert A. Brodsky
Robert Brodsky
Sabine Anna Opitz
Sixten Körper
Ursula Kalhammer
Wilhelm Leopold
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials